Throughout the evening the discussions will detail the history of research of rapamycin in longevity, upcoming crowdfunds, and how the PEARL study will provide a new groundbreaking framework for future trials aiding in human longevity. Dr. Zalzala and his team at AgelessRx plan on being an active participant and pioneer to drive research into longevity and providing a route of access rooted in science and safety.